A

Aprogen Biologics Inc
KRX:003060

Watchlist Manager
Aprogen Biologics Inc
KRX:003060
Watchlist
Price: 490 KRW 3.16% Market Closed
Market Cap: 97.2B KRW

Profitability Summary

Aprogen Biologics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Aprogen Biologics Inc

Margins Comparison
Aprogen Biologics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Aprogen Biologics Inc
KRX:003060
96.8B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Aprogen Biologics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Aprogen Biologics Inc
KRX:003060
96.8B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Aprogen Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate